Major genomics study retracted for irreproducible results and flawed conclusions

Researchers have identified serious flaws in a 2020 genomics paper that make its findings unreliable, raising questions about peer review in high-impact journals. The discovery underscores growing concerns about reproducibility in genomic research and highlights risks for companies and institutions relying on published genomic studies for product development or clinical decisions.

Originaltitel: Irreproducible results and unsupported conclusions in Ahmad et al. [BMC genomics (2020) 21:656]